A Stable, Sustainable and Strong PBS:
Needed now more than ever in a
rapidly changing healthcare landscape
The Future of M...
PBS role in healthcare
• The PBS has been a key driver in increasing Australians’ life
expectancy over the past 65 years
2
The PBS is sustainable
3
• PBS spending fell by 3.5%, or $356M in 2012-13
• Another drop of $537M is estimated for 2013-14
The PBS is sustainable
4
• PBS spending as a percentage of the Health
budget is in long-term decline
There have been repeated
downward revisions of PBS
expenditure over recent
years
PBS expenditure in decline
5
The PBS is s...
6
• Australia is behind the OECD in medicines spending
Reasons for Reform
Where Australia ranks
7
Country Innovation profile (NCEs launched vs. Market Share achieved)
EU average 2.3%
NCEs=82
0.0%
...
Paths of reform
8
Reasons for Reform
9
Source: M Wonder, Development of Industry
Relevant Key Performance Indicators for the
Pharmaceutical ...
Reasons for Reform
10
Source: Cheema, P. 2010 “International
variability in the reimbursement of cancer drugs
by publicall...
Reasons for reform
• Australian medicines exports dropped 13.5% last year
11
12
Risks facing Australian patients
0
5
10
15
20
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
Num...
The right road of reform
• All access proposals on the table and examined properly
• Innovation rewarded and protected
• R...
Upcoming SlideShare
Loading in …5
×

Elizabeth de Somer - Medicines Australia - Where does PBS stand in this reforming Australian healthcare landscape?

623 views

Published on

Elizabeth de Somer delivered the presentation at the 2014 Future of Medicare Conference.

The Future of Medicare Conference was a timely event as the Abbott government debates a full over haul of the Australian healthcare system. This conference presented a chance for government representatives, regulators, health care providers in the public and private sector, educators and private investors to come together and debate the proposed changes to Medicare as well as discuss the best practice methods of implementing new measures and frameworks.

For more information about the event, please visit: http://bit.ly/FutureofMedicare2014

Published in: Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
623
On SlideShare
0
From Embeds
0
Number of Embeds
6
Actions
Shares
0
Downloads
14
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Elizabeth de Somer - Medicines Australia - Where does PBS stand in this reforming Australian healthcare landscape?

  1. 1. A Stable, Sustainable and Strong PBS: Needed now more than ever in a rapidly changing healthcare landscape The Future of Medicare 13 August 2014 Elizabeth De Somer Director, Policy & Advocacy Medicines Australia 1
  2. 2. PBS role in healthcare • The PBS has been a key driver in increasing Australians’ life expectancy over the past 65 years 2
  3. 3. The PBS is sustainable 3 • PBS spending fell by 3.5%, or $356M in 2012-13 • Another drop of $537M is estimated for 2013-14
  4. 4. The PBS is sustainable 4 • PBS spending as a percentage of the Health budget is in long-term decline
  5. 5. There have been repeated downward revisions of PBS expenditure over recent years PBS expenditure in decline 5 The PBS is sustainable
  6. 6. 6 • Australia is behind the OECD in medicines spending Reasons for Reform
  7. 7. Where Australia ranks 7 Country Innovation profile (NCEs launched vs. Market Share achieved) EU average 2.3% NCEs=82 0.0% 0.5% 1.0% 1.5% 2.0% 2.5% 3.0% 3.5% 4.0% 4.5% 5.0% 5.5% 6.0% 0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 NCEs(2008-12)MarketShareofTotalRXmarket Number of NCEs (2008-12) launched New Zealand Australia UK Switzerland Sweden Spain Slovenia Slovakia Romania Portugal Poland Netherlands Luxembourg LithuaniaLatvia Italy Ireland Hungary Greece Germany France Finland Estonia Czech R. Bulgaria Belgium Austria Norway EU average n46
  8. 8. Paths of reform 8
  9. 9. Reasons for Reform 9 Source: M Wonder, Development of Industry Relevant Key Performance Indicators for the Pharmaceutical Benefits Scheme (2010-2013) Report prepared for Medicines Australia, May 2014
  10. 10. Reasons for Reform 10 Source: Cheema, P. 2010 “International variability in the reimbursement of cancer drugs by publically funded drug programs”, Medical Oncology, v. 19, n. 3, http://www.current- oncology.com/index.php/oncology/article/view /946/924 (accessed 4/10/2013 ) International access to cancer medicines
  11. 11. Reasons for reform • Australian medicines exports dropped 13.5% last year 11
  12. 12. 12 Risks facing Australian patients 0 5 10 15 20 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 NumberofMedicineslistedinAustralia Reimbursed in Aus and NZ Medicines that are reimbursed in Aus but not NZ Source: PBS (Australia), PHARMAC (NZ) Additional medicines listed for reimbursement in Australia vs medicines not reimbursed in NZ
  13. 13. The right road of reform • All access proposals on the table and examined properly • Innovation rewarded and protected • Red tape reduction • Health technology assessment processes improved • Consider options to diversify medicines funding 13

×